Being a principal investigator (PI) is tough. So tough, in fact, that more than half of new investigators give up after their first FDA-regulated drug trial.
CRA/CRC Shortages Slow Clinical Trial Pace
As clinical trials continue to change, the evolving roles of CRAs and CRCs are exacerbating the problems sponsors and CROs have finding well-trained candidates.